The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-oxo-5-phenyl-N7-(3'-deoxy-3'-fluoro-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine ID: ALA4878319
PubChem CID: 164626050
Max Phase: Preclinical
Molecular Formula: C17H16FN3O4
Molecular Weight: 345.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]cnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](CO)[C@@H](F)[C@H]1O
Standard InChI: InChI=1S/C17H16FN3O4/c18-13-11(7-22)25-17(14(13)23)21-6-10(9-4-2-1-3-5-9)12-15(21)19-8-20-16(12)24/h1-6,8,11,13-14,17,22-23H,7H2,(H,19,20,24)/t11-,13-,14-,17-/m1/s1
Standard InChI Key: JMNOKJVIKYOURK-LSCFUAHRSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
40.4138 -11.5687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2310 -11.5687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4854 -10.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8224 -10.3098 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.1636 -10.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9326 -12.2292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
41.7105 -12.2303 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.3863 -10.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2629 -10.5405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2161 -9.7405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.3333 -9.7651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5161 -9.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5847 -10.5426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9189 -11.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9987 -11.8304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.7433 -12.1703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4091 -11.6933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.3304 -10.8763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9940 -10.3994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.8103 -9.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6239 -9.1933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.1049 -8.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7736 -7.7857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9565 -7.7013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4791 -8.3620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 1 6
2 7 1 6
5 8 1 1
3 9 1 1
8 10 1 0
9 14 1 0
13 11 1 0
11 12 2 0
12 9 1 0
13 14 2 0
13 18 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
11 20 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 345.33Molecular Weight (Monoisotopic): 345.1125AlogP: 0.98#Rotatable Bonds: 3Polar Surface Area: 100.37Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.75CX Basic pKa: 1.66CX LogP: 0.87CX LogD: 0.87Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.66Np Likeness Score: 0.31
References 1. Bouton J, Furquim d'Almeida A, Maes L, Caljon G, Van Calenbergh S, Hulpia F.. (2021) Synthesis and evaluation of 3'-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents., 216 [PMID:33667845 ] [10.1016/j.ejmech.2021.113290 ]